The chondroitin sulfate proteoglycan 4 (CSPG4) antigen also known as MCSP is strongly expressed on 90% of melanoma cancer cell lines, and other tumors such as glioblastoma, sarcoma, and leukemia. Here, CSPG4 is linked to leukemia.